1.0500
+0.0100
+(0.96%)
At close: January 24 at 4:00:00 PM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-9,490.5370
-9,490.5370
-7,695.2420
-5,468.0650
-1,600.1980
Investing Cash Flow
--
--
-5.9160
-1.6690
-18.1140
Financing Cash Flow
6,208.5080
6,208.5080
9,323.3540
2,153.2700
7,826.9380
End Cash Position
826.8480
826.8480
4,045.3810
2,700.7240
6,889.3290
Capital Expenditure
--
--
-5.9160
-1.6690
-6.9430
Issuance of Capital Stock
6,208.5080
6,208.5080
7,323.3540
--
230.0190
Issuance of Debt
--
--
2,000.0000
--
7,593.3800
Repayment of Debt
--
--
--
--
-12.3310
Free Cash Flow
-9,490.5370
-9,490.5370
-7,701.1580
-5,469.7340
-1,607.1410
3/31/2021 - 5/17/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FBLG FibroBiologics, Inc.
1.6800
+5.00%
ICUCW SeaStar Medical Holding Corporation
0.0300
0.00%
AKTX Akari Therapeutics, Plc
1.1577
-2.71%
ACUT AccuStem Sciences, Inc.
0.4028
0.00%
ATHA Athira Pharma, Inc.
0.5550
+0.02%
ESLA Estrella Immunopharma, Inc.
1.1300
0.00%
XRTX XORTX Therapeutics Inc.
0.9100
-0.66%
TNFA TNF Pharmaceuticals, Inc.
1.1900
+3.48%
PSTV Plus Therapeutics, Inc.
1.2300
+1.65%
AVTE Aerovate Therapeutics, Inc.
2.5900
+1.17%